Wellstar International, Inc. Announces Installation and Training Completed

Wellstar International Inc. (OTCBB: WLSI) has announced they will be installing a system in Torrance, California.

Wellstar has installed and trained the staff for the TMI Imaging system in a Physician’s office in Torrance, California. The system will be used primarily for the detection of inflammation and neuropathy. This is an installation and not part of a beta test.

The practice specializes in treating patients with diabetes. Neuropathy, inflammation and lack of circulation are very prevalent with diabetes. The TMI System will be able to detect and track the inflammation, neuropathy and possible deep tissue damage caused by lack of circulation. The tracking is a tool that the physician is looking forward to using to see how the patient is responding to the treatment(s).

Initially the patient will be imaged, thus creating a baseline. Since the system does not emit any radiation, the doctor will continue to image his patients without any harm to the patient before and after each treatment, thus tracking the progress.

The physician’s practice is very excited about the use of this diagnostic tool and to be able to give better patient care.

With diabetes being a severe problem globally, Wellstar hopes to place several hundred of these systems when they obtain the results of the install over the next several months after showing the success of this current install.

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operation results.